Francisca Villavicencio Tejo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Francisca Villavicencio Tejo has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Rodrigo A. Quintanilla
Laboratory of Neurodegenerative Diseases, Instituto de Ciencias Biomédicas, Facultad de Ciencias de La Salud, Universidad Autónoma de Chile, Santiago, Chile
2 shared publications - Alejandra Aránguiz
Laboratory of Neurodegenerative Diseases, Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Santiago 8910060, Chile
1 shared publication - Macarena Valladares
Universidad Bernardo O’Higgins, Santiago, Chile
1 shared publication - Margrethe A. Olesen
Laboratory of Neurodegenerative Diseases, Universidad Autónoma de Chile, Santiago, Chile
1 shared publication - Patricio Ibarra Cifuentes
Universidad Bernardo O´Higgins
1 shared publication
Latest Publications
- Open Access
- 8 March 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (3) , 515
Activation of the Nrf2 Pathway Prevents Mitochondrial Dysfunction Induced by Caspase-3 Cleaved Tau: Implications for Alzheimer’s Disease
Alzheimer’s disease (AD) is characterized by memory and cognitive impairment, accompanied by the accumulation of extracellular deposits of amyloid β-peptide (Aβ) and the presence of neurofibrillary tangles (NFTs) composed of pathological forms of tau protein. Mitochondrial dysfunction and oxidative stress are also critical elements for AD development. We previously showed that the presence of caspase-3 cleaved tau, a relevant pathological form of tau in AD, induced mitochondrial dysfunction and oxidative damage in different neuronal models. Recent studies demonstrated that the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) plays a significant role in the antioxidant response promoting neuroprotection. Here, we studied the effects of Nrf2 activation using sulforaphane (SFN) against mitochondrial injury induced by caspase-3 cleaved tau. We used immortalized cortical neurons to evaluate mitochondrial bioenergetics and ROS levels in control and SFN-treated cells. Expression of caspase-3 cleaved tau induced mitochondrial fragmentation, depolarization, ATP loss, and increased ROS levels. Treatment with SFN for 24 h significantly prevented these mitochondrial abnormalities, and reduced ROS levels. Analysis of Western blots and rt-PCR studies showed that SFN treatment increased the expression of several Nrf2-related antioxidants genes in caspase-3 cleaved tau cells. These results indicate a potential role of the Nrf2 pathway in preventing mitochondrial dysfunction induced by pathological forms of tau in AD.
- 8 March 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (3) , 515
Open AccessActivation of the Nrf2 Pathway Prevents Mitochondrial Dysfunction Induced by Caspase-3 Cleaved Tau: Implications for Alzheimer’s Disease
Alzheimer’s disease (AD) is characterized by memory and cognitive impairment, accompanied by the accumulation of extracellular deposits of amyloid β-peptide (Aβ) and the presence of neurofibrillary tangles (NFTs) composed of pathological forms of tau protein. Mitochondrial dysfunction and oxidative stress are also critical elements for AD development. We previously showed that the presence of caspase-3 cleaved tau, a relevant pathological form of tau in AD, induced mitochondrial dysfunction and oxidative damage in different neuronal models. Recent studies demonstrated that the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) plays a significant role in the antioxidant response promoting neuroprotection. Here, we studied the effects of Nrf2 activation using sulforaphane (SFN) against mitochondrial injury induced by caspase-3 cleaved tau. We used immortalized cortical neurons to evaluate mitochondrial bioenergetics and ROS levels in control and SFN-treated cells. Expression of caspase-3 cleaved tau induced mitochondrial fragmentation, depolarization, ATP loss, and increased ROS levels. Treatment with SFN for 24 h significantly prevented these mitochondrial abnormalities, and reduced ROS levels. Analysis of Western blots and rt-PCR studies showed that SFN treatment increased the expression of several Nrf2-related antioxidants genes in caspase-3 cleaved tau cells. These results indicate a potential role of the Nrf2 pathway in preventing mitochondrial dysfunction induced by pathological forms of tau in AD.
- Open Access
- 2 July 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (7) , 1069
Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease
The increase in human life expectancy has become a challenge to reduce the deleterious consequences of aging. Nowadays, an increasing number of the population suffer from age-associated neurodegenerative diseases including Parkinson’s disease (PD) and Alzheimer’s disease (AD). These disorders present different signs of neurodegeneration such as mitochondrial dysfunction, inflammation, and oxidative stress. Accumulative evidence suggests that the transcriptional factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) plays a vital defensive role orchestrating the antioxidant response in the brain. Nrf2 activation promotes the expression of several antioxidant enzymes that exert cytoprotective effects against oxidative damage and mitochondrial impairment. In this context, several studies have proposed a role of Nrf2 in the pathogenesis of PD and AD. Thus, we consider it important to summarize the ongoing literature related to the effects of the Nrf2 pathway in the context of these diseases. Therefore, in this review, we discuss the mechanisms involved in Nrf2 activity and its connection with mitochondria, energy supply, and antioxidant response in the brain. Furthermore, we will lead our discussion to identify the participation of the Nrf2 pathway in mitochondrial impairment and neurodegeneration present in PD and AD. Finally, we will discuss the therapeutic effects that the Nrf2 pathway activation could have on the cognitive impairment, neurodegeneration, and mitochondrial failure present in PD and AD.
- 2 July 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (7) , 1069
Open AccessContribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease
The increase in human life expectancy has become a challenge to reduce the deleterious consequences of aging. Nowadays, an increasing number of the population suffer from age-associated neurodegenerative diseases including Parkinson’s disease (PD) and Alzheimer’s disease (AD). These disorders present different signs of neurodegeneration such as mitochondrial dysfunction, inflammation, and oxidative stress. Accumulative evidence suggests that the transcriptional factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) plays a vital defensive role orchestrating the antioxidant response in the brain. Nrf2 activation promotes the expression of several antioxidant enzymes that exert cytoprotective effects against oxidative damage and mitochondrial impairment. In this context, several studies have proposed a role of Nrf2 in the pathogenesis of PD and AD. Thus, we consider it important to summarize the ongoing literature related to the effects of the Nrf2 pathway in the context of these diseases. Therefore, in this review, we discuss the mechanisms involved in Nrf2 activity and its connection with mitochondria, energy supply, and antioxidant response in the brain. Furthermore, we will lead our discussion to identify the participation of the Nrf2 pathway in mitochondrial impairment and neurodegeneration present in PD and AD. Finally, we will discuss the therapeutic effects that the Nrf2 pathway activation could have on the cognitive impairment, neurodegeneration, and mitochondrial failure present in PD and AD.
- Open Access
- 1 August 2018
- Published by Universidad de Tarapacá in Diálogo andino
- No. 56,p. 75-85
LA INGESTA DE ALIMENTOS DE LOS SOLDADOS CHILENOS DURANTE LA GUERRA DEL PACÍFICO (1879-1883): UNA APROXIMACIÓN HISTÓRICA Y NUTRICIONAL
El objetivo de este trabajo es determinar si el tipo y la cantidad de alimentos consumidos por los soldados chilenos durante la Guerra del Pacífico (1879-1883) fueron los apropiados para cubrir sus necesidades, además de conocer parte de la rutina diaria de nutrición. La metodología utilizada fue caracterizar el tipo y calcular los ingredientes y gramos de los alimentos consumidos por los soldados, descritos en documentos oficiales chilenos, luego se calculó la cantidad de energía total diaria y macronutrientes ingeridos por los soldados. Los resultados obtenidos mostraron una mayor ingesta de energía (3.867 Kcal vs. 2.688 Kcal) y macronutrientes durante la estancia en los cuarteles que en el campamento. Hay una mayor variabilidad en el tipo de alimento durante la estancia en los cuarteles, comiendo frijoles (350 g), trigo picado (120 g) y papas frescas (150 g), cosas que no ingerían durante el campamento. El porcentaje de carbohidratos y proteínas consumidos por los soldados (barracas y campamentos) está dentro del rango establecido hoy, sin embargo, los niveles de lípidos están por encima de los porcentajes determinados.
- 1 August 2018
- Published by Universidad de Tarapacá in Diálogo andino
- No. 56,p. 75-85
Open AccessLA INGESTA DE ALIMENTOS DE LOS SOLDADOS CHILENOS DURANTE LA GUERRA DEL PACÍFICO (1879-1883): UNA APROXIMACIÓN HISTÓRICA Y NUTRICIONAL
El objetivo de este trabajo es determinar si el tipo y la cantidad de alimentos consumidos por los soldados chilenos durante la Guerra del Pacífico (1879-1883) fueron los apropiados para cubrir sus necesidades, además de conocer parte de la rutina diaria de nutrición. La metodología utilizada fue caracterizar el tipo y calcular los ingredientes y gramos de los alimentos consumidos por los soldados, descritos en documentos oficiales chilenos, luego se calculó la cantidad de energía total diaria y macronutrientes ingeridos por los soldados. Los resultados obtenidos mostraron una mayor ingesta de energía (3.867 Kcal vs. 2.688 Kcal) y macronutrientes durante la estancia en los cuarteles que en el campamento. Hay una mayor variabilidad en el tipo de alimento durante la estancia en los cuarteles, comiendo frijoles (350 g), trigo picado (120 g) y papas frescas (150 g), cosas que no ingerían durante el campamento. El porcentaje de carbohidratos y proteínas consumidos por los soldados (barracas y campamentos) está dentro del rango establecido hoy, sin embargo, los niveles de lípidos están por encima de los porcentajes determinados.